KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $35.8 billion.

  • Gilead Sciences' Total Non-Current Liabilities rose 308.59% to $35.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $35.8 billion, marking a year-over-year increase of 308.59%. This contributed to the annual value of $38.4 billion for FY2024, which is 276.67% up from last year.
  • Per Gilead Sciences' latest filing, its Total Non-Current Liabilities stood at $35.8 billion for Q3 2025, which was up 308.59% from $34.8 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Total Non-Current Liabilities registered a high of $43.7 billion during Q2 2021, and its lowest value of $34.0 billion during Q2 2024.
  • In the last 5 years, Gilead Sciences' Total Non-Current Liabilities had a median value of $38.0 billion in 2023 and averaged $38.1 billion.
  • As far as peak fluctuations go, Gilead Sciences' Total Non-Current Liabilities skyrocketed by 3609.66% in 2021, and later plummeted by 1208.55% in 2024.
  • Over the past 5 years, Gilead Sciences' Total Non-Current Liabilities (Quarter) stood at $42.1 billion in 2021, then dropped by 9.67% to $38.0 billion in 2022, then fell by 1.86% to $37.3 billion in 2023, then rose by 2.77% to $38.4 billion in 2024, then decreased by 6.67% to $35.8 billion in 2025.
  • Its last three reported values are $35.8 billion in Q3 2025, $34.8 billion for Q2 2025, and $35.9 billion during Q1 2025.